Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.

Abdominal aortic aneurysm (AAA), an inflammatory disease, involves leukocyte recruitment, immune responses, inflammatory cytokine production, vascular remodeling, neovascularization, and vascular cell apoptosis, all of which contribute to aortic dilatation. This study demonstrates that mast cells, key participants in human allergic immunity, participate in AAA pathogenesis in mice. Mast cells were found to accumulate in murine AAA lesions. Mast cell-deficient KitW-sh/KitW-sh mice failed to develop AAA elicited by elastase perfusion or periaortic chemical injury. KitW-sh/KitW-sh mice had reduced aortic expansion and internal elastic lamina degradation; decreased numbers of macrophages, CD3+ T lymphocytes, SMCs, apoptotic cells, and CD31+ microvessels; and decreased levels of aortic tissue IL-6 and IFN-gamma. Activation of mast cells in WT mice via C48/80 injection resulted in enhanced AAA growth while mast cell stabilization with disodium cromoglycate diminished AAA formation. Mechanistic studies demonstrated that mast cells participated in angiogenesis, aortic SMC apoptosis, and matrix-degrading protease expression. Reconstitution of KitW-sh/KitW-sh mice with bone marrow-derived mast cells from WT or TNF-alpha-/- mice, but not from IL-6-/- or IFN-gamma-/- mice, caused susceptibility to AAA formation to be regained. These results demonstrate that mast cells participate in AAA pathogenesis in mice by releasing proinflammatory cytokines IL-6 and IFN-gamma, which may induce aortic SMC apoptosis, matrix-degrading protease expression, and vascular wall remodeling, important hallmarks of arterial aneurysms.

[1]  Richard T. Lee,et al.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. , 2004, The Journal of clinical investigation.

[2]  A. Zelenetz,et al.  The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. van der Made,et al.  Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation , 2005, Circulation.

[4]  M. Ihara,et al.  Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. , 1999, Hypertension.

[5]  P. Wolters,et al.  Tissue‐selective mast cell reconstitution and differential lung gene expression in mast cell‐deficient KitW‐sh/KitW‐sh sash mice , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  D. Woolley.  The mast cell in inflammatory arthritis. , 2003, The New England journal of medicine.

[7]  K. Newman,et al.  Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. , 1994, Circulation.

[8]  M. Fishbein,et al.  Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. , 1990, The American journal of pathology.

[9]  M. Aridor,et al.  Activation of exocytosis by the heterotrimeric G protein Gi3. , 1993, Science.

[10]  J. Boyce,et al.  Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. , 2006, The Journal of allergy and clinical immunology.

[11]  S. Zuckerman,et al.  Gamma interferon: a central mediator in atherosclerosis , 2005, Inflammation Research.

[12]  Christoph Peters,et al.  Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice , 2007, Circulation.

[13]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[14]  Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Gorav Ailawadi,et al.  Current concepts in the pathogenesis of abdominal aortic aneurysm. , 2003, Journal of vascular surgery.

[16]  G. K. Iwamoto,et al.  Interferon-gamma regulation of interleukin 6 in monocytic cells. , 1994, The American journal of physiology.

[17]  V. Videm,et al.  Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm Repair , 2003, Circulation.

[18]  J. Hiscott,et al.  Molecular mechanisms regulating induction of interleukin‐6 gene transcription by interferon‐γ , 1997, European journal of immunology.

[19]  W. Paton,et al.  Compound 48/80: a potent histamine liberator. , 1951, British journal of pharmacology and chemotherapy.

[20]  R. Homer,et al.  Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.

[21]  B. Echtenacher,et al.  Critical protective role of mast cells in a model of acute septic peritonitis , 1996, Nature.

[22]  J. Powell,et al.  Interleukin-6 (IL-6) and the Prognosis of Abdominal Aortic Aneurysms , 2001, Circulation.

[23]  R. Crystal,et al.  Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. , 1981, Science.

[24]  K. Karalis,et al.  Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. , 2003, Cardiovascular research.

[25]  P. Libby,et al.  Lysosomal Cysteine Proteases in Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Hiroshi Ito,et al.  Enhanced Tumor Necrosis Factor-α Expression in Small Sized Abdominal Aortic Aneurysms , 2003, World Journal of Surgery.

[27]  Hiroshi Ito,et al.  Enhanced tumor necrosis factor- alpha expression in small sized abdominal aortic aneurysms. , 2003, World journal of surgery.

[28]  E. Choke,et al.  Abdominal Aortic Aneurysm Rupture Is Associated With Increased Medial Neovascularization and Overexpression of Proangiogenic Cytokines , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Makoto Naito,et al.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[30]  R. Graham,et al.  Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. , 2004, The Journal of clinical investigation.

[31]  S. Toda,et al.  Mast cells and angiogenesis , 2003, Microscopy research and technique.

[32]  M. Aoki,et al.  Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model , 2005, Gene Therapy.

[33]  M. Seishima,et al.  Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. , 2000, Atherosclerosis.

[34]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[35]  M. Tsai,et al.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Greiner,et al.  Key Roles of CD4+ T Cells and IFN-γ in the Development of Abdominal Aortic Aneurysms in a Murine Model1 , 2004, The Journal of Immunology.

[37]  B. Ryffel,et al.  Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. , 2005, Immunity.

[38]  P. Kovanen.  Role of mast cells in atherosclerosis. , 1995, Chemical immunology.

[39]  S. Lazarus,et al.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. , 1996, The Journal of clinical investigation.

[40]  G. Ailawadi,et al.  Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.

[41]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[42]  S. Takai,et al.  A Specific Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppresses Development of Abdominal Aortic Aneurysm in Hamsters , 2004, Journal of Pharmacology and Experimental Therapeutics.

[43]  R. Schlegel,et al.  Induction of Apoptosis by Pyrrolidinedithiocarbamate and N-Acetylcysteine in Vascular Smooth Muscle Cells (*) , 1996, The Journal of Biological Chemistry.

[44]  Robert W. Thompson,et al.  Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms , 2007, Proceedings of the National Academy of Sciences.

[45]  T. Ley,et al.  Dipeptidyl Peptidase I Is Essential for Activation of Mast Cell Chymases, but Not Tryptases, in Mice* , 2001, The Journal of Biological Chemistry.

[46]  M. Åbrink,et al.  A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.

[47]  Nakahata,et al.  The effects of anti‐asthma drugs on mediator release from cultured human mast cells , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  C. Chen,et al.  Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. , 2005, The American journal of pathology.

[49]  P. Libby,et al.  Mast cells promote atherosclerosis by releasing proinflammatory cytokines , 2007, Nature Medicine.

[50]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  Robert W. Thompson,et al.  Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. , 2003, Journal of vascular surgery.

[52]  P. Conti,et al.  MCP-1 and RANTES are mediators of acute and chronic inflammation. , 2001, Allergy and asthma proceedings.

[53]  V. Turk,et al.  Lysosomal Cysteine Proteases: Structural Features and their Role in Apoptosis , 2005, IUBMB life.

[54]  M. Halks-Miller,et al.  Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis , 2005, Circulation.

[55]  H. Chapman,et al.  Mast Cell Cathepsins C and S Control Levels of Carboxypeptidase A and the Chymase, Mouse Mast Cell Protease 5 , 2003, Biological chemistry.

[56]  C. Gutekunst,et al.  Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course 1 , 2003, The Journal of Immunology.

[57]  A. Sajantila,et al.  Mast Cells in Neovascularized Human Coronary Plaques Store and Secrete Basic Fibroblast Growth Factor, a Potent Angiogenic Mediator , 2004, Arteriosclerosis, thrombosis, and vascular biology.